Skip to main content

Cancer Letters

  • ISSN: 0304-3835

Editor-In-Chief: Li

Next planned ship date: May 23, 2024

  • 5 Year impact factor: 8.9
  • Impact factor: 9.7

An international journal providing a forum for original and pertinent contributions in cancer research Cancer Letters is an international journal that considers full-lengt… Read more

Subscription options

Next planned ship date:
May 23, 2024

Institutional subscription on ScienceDirect

Request a sales quote
An international journal providing a forum for original and pertinent contributions in cancer research

Cancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine, including metronomic chemotherapy.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.com.